Pharsight

PFIZER PATENTS FACING OPPOSITIONS

Top patents of PFIZER facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2968155B1 03 Mar, 2021 Tofacitinib oral sustained release dosage forms Mar, 2034 6
EP3302565B1 06 Nov, 2019 Solid dosage forms of palbociclib May, 2036 6
EP3191461B1 03 Nov, 2021 Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole Aug, 2035 5
EP3431475B1 07 Apr, 2021 Solid forms of a selective cdk4/6 inhibitor Feb, 2034 4
EP3096785B1 09 Sep, 2020 Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof Jan, 2035 3
EP2958916B1 12 Sep, 2018 Solid forms of a selective cdk4/6 inhibitor Feb, 2034 3
EP2357250B1 06 Oct, 2021 Production of TNFR-Ig Aug, 2025 2
EP1789571B1 26 Apr, 2017 Production of TNFR-Ig in a large-scale production cell culture Aug, 2025 2
EP2134702B2 30 Aug, 2023 Crystalline forms of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-e-[2-(pyridin-2-yl)ethenyl]indazole suitable for the treatment of abnormal cell growth in mammals Mar, 2028 1
EP3269717B9 09 Aug, 2023 Polymorphic and pseudopolymorphic forms of pharmaceutical compound nxl104 Oct, 2030 1
EP3555064B9 01 Mar, 2023 Glp-1 receptor agonists and uses thereof Dec, 2037 1
EP3459578B1 03 Mar, 2021 Dispensing device Jun, 2024 1
EP3150610B1 31 Jul, 2019 Salts and polymorphs of 8-fluoro-2-{4-[(methylamino}methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one Feb, 2031 1
EP2752216B1 07 Nov, 2018 Dispensing device Jun, 2024 1